B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous System

por Pavelko, Kevin D., Bell, Michael P., Harrington, Susan M., Dong, Haidong
Publicado 2017

B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8(+) T cells

por Liu, Xin, Wu, Xiaosheng, Cao, Siyu, Harrington, Susan M., Yin, Peng, Mansfield, Aaron S., Dong, Haidong
Publicado 2016

CpG-induced antitumor immunity requires IL-12 in expansion of effector cells and down-regulation of PD-1

por Yin, Peng, Liu, Xin, Mansfield, Aaron S., Harrington, Susan M., Li, Yinghua, Yan, Yiyi, Dong, Haidong
Publicado 2016

B7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating Bim

por Gibbons, Rachel M., Liu, Xin, Pulko, Vesna, Harrington, Susan M., Krco, Christopher J., Kwon, Eugene D., Dong, Haidong
Publicado 2012

Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth

por Liu, Xin, Gibbons, Rachel M., Harrington, Susan M., Krco, Christopher J., Markovic, Svetomir N., Kwon, Eugene D., Dong, Haidong
Publicado 2013

Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy

por Enninga, Elizabeth Ann L., Harrington, Susan M., Creedon, Douglas J., Ruano, Rodrigo, Markovic, Svetomir N., Dong, Haidong, Dronca, Roxana S.
Publicado 2017

A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration–Approved PD-1 and PD-L1 Inhibitors

por Barham, Whitney, Hsu, Michelle, Liu, Xin, Harrington, Susan M., Hirdler, Jacob B., Gicobi, Joanina K., Zhu, Xingxing, Zeng, Hu, Pavelko, Kevin D., Yan, Yiyi, Mansfield, Aaron S., Dong, Haidong
Publicado 2023

Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy

por Wu, Xiaosheng, Li, Yanli, Liu, Xin, Chen, Chunhua, Harrington, Susan M., Cao, Siyu, Xie, Tiancheng, Pham, Tu, Mansfield, Aaron S., Yan, Yiyi, Kwon, Eugene D., Wang, Liewei, Ling, Kun, Dong, Haidong
Publicado 2018

Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]

por Wu, Xiaosheng, Li, Yanli, Liu, Xin, Chen, Chunhua, Harrington, Susan M., Cao, Siyu, Xie, Tiancheng, Pham, Tu, Mansfield, Aaron S., Yan, Yiyi, Kwon, Eugene D., Wang, Liewei, Ling, Kun, Dong, Haidong
Publicado 2019

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles

por Orme, Jacob J, Enninga, Elizabeth Ann L, Lucien-Matteoni, Fabrice, Dale, Heather, Burgstaler, Edwin, Harrington, Susan M, Ball, Matthew K, Mansfield, Aaron S, Park, Sean S, Block, Mathew S, Markovic, Svetomir N, Yan, Yiyi, Dong, Haidong, Dronca, Roxana S, Winters, Jeffrey L
Publicado 2020

Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels

por Sideras, Kostandinos, de Man, Robert A., Harrington, Susan M., Polak, Wojciech G., Zhou, Guoying, Schutz, Hannah M., Pedroza-Gonzalez, Alexander, Biermann, Katharina, Mancham, Shanta, Hansen, Bettina E., Bart Takkenberg, R., van Vuuren, Anneke J., Pan, Qiuwei, Ijzermans, Jan N. M., Sleijfer, Stefan, Sprengers, Dave, Dong, Haidong, Kwekkeboom, Jaap, Bruno, Marco J.
Publicado 2019

NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

por Wen, Ti, Barham, Whitney, Li, Ying, Zhang, Henan, Gicobi, Joanina K., Hirdler, Jacob B., Liu, Xin, Ham, Hyoungjun, Peterson Martinez, Kodi E., Lucien, Fabrice, Lavoie, Roxane R., Li, Hu, Correia, Cristina, Monie, Dileep D., An, Zesheng, Harrington, Susan M., Wu, Xiaosheng, Guo, Ruifeng, Dronca, Roxana S., Mansfield, Aaron S., Yan, Yiyi, Markovic, Svetomir N., Park, Sean S., Sun, Jie, Qin, Hong, Liu, Minetta C., Vasmatzis, George, Billadeau, Daniel D., Dong, Haidong
Publicado 2022